Medicago to kick off large study of COVID-19 vaccine with GSK booster
The news comes days after early-stage data showed Medicago's plant-based vaccine candidate produced virus-fighting antibodies in all volunteers. Medicago, backed by cigarette maker Philip Morris International, is Canada's most advanced COVID-19 vaccine project, but lags larger, global rivals

Full story is loading. Click here if it doesn't...